PCN79 IMPACT of Adjuvant Trastuzumab Emtansine (T-DM1) on the Incidence of HER2-Positive Metastatic Breast Cancer and Its Associated Savings for the Spanish National Healthcare System
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.216
https://www.valueinhealthjournal.com/article/S1098-3015(20)32472-4/fulltext
Title :
PCN79 IMPACT of Adjuvant Trastuzumab Emtansine (T-DM1) on the Incidence of HER2-Positive Metastatic Breast Cancer and Its Associated Savings for the Spanish National Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32472-4&doi=10.1016/j.jval.2020.08.216
First page :
Section Title :
Open access? :
No
Section Order :
10165